Ucyclyd Pharma Inc is categorized under Proprietary (Patent) Medicines, Nec in Scottsdale, AZ and active since 2013.
Ucyclyd Pharma Inc was established in 2013, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Proprietary (Patent) Medicines, Nec business, which does work in the B2B market, and is classified as a Proprietary (Patent) Medicines, Nec, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Joseph Cooper at the company’s single location by writing to 8125 North Hayden Road, Scottsdale, Arizona AZ 85258 or by phoning (602) 808-8800. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Ucyclyd Pharma Inc |
Contact Person: | Joseph Cooper |
Address: | 8125 North Hayden Road, Scottsdale, Arizona 85258 |
Phone Number: | (602) 808-8800 |
Website Address: | valeant.com |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2013 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Proprietary (Patent) Medicines, Nec |
SIC Code: | 5122 |
NAICS Code: | 424210 |
Share This Business: |
Ucyclyd Pharma Inc was started in 2013 to provide professional Proprietary (Patent) Medicines, Nec under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Joseph Cooper for inquiries that concern Ucyclyd Pharma Inc by calling the company number (602) 808-8800, as your correspondence is most welcome. Additionally, the physical location of the single location of Ucyclyd Pharma Inc can be found at the coordinates 33.555152,-111.898346 as well as the street address 8125 North Hayden Road in Scottsdale, Arizona 85258.
For its online presence, you may visit Ucyclyd Pharma Inc’s website at valeant.com and engage with its social media outlets through on Twitter and on Facebook.